Evidence map›Paper›PMID 16681145›Full record

ArticleFolia microbiologica2005

A rapid screening method for detecting active compounds against erythromycin-resistant bacterial strains of Finnish origin.

K Kreander, P Vuorela, P Tammela

Abstract readEvaluation Study
PubMed Publisher
In one paragraph

Article in Folia microbiologica, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Analytical cellular pathology (Amsterdam) · 2016
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

K KreanderDrug Discovery and Development Technology Center, Faculty of Pharmacy, University of Helsinki, Finland.
P Vuorela
P Tammela

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A rapid and simple microdilution technique on 96-well microplate based on turbidimetry was optimized and validated for screening of antimicrobial activity against erythromycin-resistant bacterial strains of Streptococcus pyogenes and Staphylococcus simulans isolated from Finnish patients. Using S. pyogenes ATCC 12351 as reference strain the developed method was evaluated by reproducibility measurements and using parameters typically employed for screening methods, i.e. signal-to-background, signal-to-noise and a screening-window coefficient, the Z' factor. The method was further used for screening a group of natural compounds and their synthetic derivatives against resistant bacterial strains. Of these, octyl and dodecyl gallates, and usnic and ursolic acids were the most active. The described method is a rapid, homogeneous, cost-effective and easy-to-perform system for screening of new potential antimicrobial agents in drug discovery.

Indexed as

Drug Resistance, BacterialAnti-Bacterial AgentsCoumarinsErythromycinFinlandFlavonoidsGallic AcidHumansHydroxybenzoatesMicrobial Sensitivity TestsNephelometry and TurbidimetryPenicillin GStaphylococcusStreptococcus pyogenesTime FactorsAnti-Bacterial AgentsCoumarinsErythromycinFlavonoidsGallic AcidHydroxybenzoateslauryl gallateoctyl gallatePenicillin Gphenolic acid

Identifiers

PMID16681145

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.